Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It’s an ideal concise reference for trainee and practicing medical oncologists, as well as those in research.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iv 5. Dedication - p. v 6. List of Contributors - p. vii 7. Preface - p. xi 8. Chapter 1. Immune Checkpoint Inhibitors: Mechanisms and Emerging Therapeutic Opportunities - p. 1 9. Chapter 2. Immune Checkpoints: Melanoma and Other Skin Cancers - p. 19 10. Chapter 3. The Current Status of Immunotherapy in Thoracic Malignancies - p. 45 11. Chapter 4. Immune Checkpoint Inhibitors in Gastrointestinal Malignancies - p. 77 12. Chapter 5. Cancers of the Head and Neck - p. 103 13. Chapter 6. Urologic Malignancies - p. 115 14. Chapter 7. Gynecologic Malignancies - p. 135 15. Chapter 8. Breast Cancer - p. 157 16. Chapter 9. Hematologic Malignancies - p. 169 17. Chapter 10. Pediatric Malignancies - p. 193 18. Chapter 11. Toxicities in Immune Checkpoint Inhibitors - p. 205 19. Chapter 12. Future of Immune Checkpoint Inhibitors - p. 227 20. Index - p. 245
No hay muestra disponible
No hay ficha técnica disponible
Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It’s an ideal concise reference for trainee and practicing medical oncologists, as well as those in research.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iv 5. Dedication - p. v 6. List of Contributors - p. vii 7. Preface - p. xi 8. Chapter 1. Immune Checkpoint Inhibitors: Mechanisms and Emerging Therapeutic Opportunities - p. 1 9. Chapter 2. Immune Checkpoints: Melanoma and Other Skin Cancers - p. 19 10. Chapter 3. The Current Status of Immunotherapy in Thoracic Malignancies - p. 45 11. Chapter 4. Immune Checkpoint Inhibitors in Gastrointestinal Malignancies - p. 77 12. Chapter 5. Cancers of the Head and Neck - p. 103 13. Chapter 6. Urologic Malignancies - p. 115 14. Chapter 7. Gynecologic Malignancies - p. 135 15. Chapter 8. Breast Cancer - p. 157 16. Chapter 9. Hematologic Malignancies - p. 169 17. Chapter 10. Pediatric Malignancies - p. 193 18. Chapter 11. Toxicities in Immune Checkpoint Inhibitors - p. 205 19. Chapter 12. Future of Immune Checkpoint Inhibitors - p. 227 20. Index - p. 245
No hay muestra disponible
No hay ficha técnica disponible
